hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06327607, orgStudyIdInfo id: IEO 1952, briefTitle: Psychosexuological Interventions to Support Sexual Function in Breast Cancer Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-06-09, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: European Institute of Oncology, class: OTHER, descriptionModule briefSummary: Prospective pilot study on the feasibility and efficacy of a brief psychosexual support intervention in breast cancer patients undergoing hormonal therapies for at least 6 months.The study is randomized in the two following arms:Control arm (standard care pathway) Psychosexual intervention arm, conditionsModule conditions: Breast Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 82, type: ESTIMATED, armsInterventionsModule interventions name: Control Group, interventions name: Psychosexological intervention, outcomesModule primaryOutcomes measure: Evaluation of differences between two arms in female sexual satisfaction and functionality scores, secondaryOutcomes measure: Evaluation of differences between two arms in levels of quality of life, secondaryOutcomes measure: Evaluation of differences between two arms in levels of anxiety and depression, secondaryOutcomes measure: Evaluation of differences between two arms in levels of sleep quality, eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: European Institute of Oncology, status: RECRUITING, city: Milan, country: Italy, contacts name: Gabriella Pravettoni, role: CONTACT, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False
protocolSection identificationModule nctId: NCT06327594, orgStudyIdInfo id: XTang-0002, briefTitle: Assessment System of Sarcopenia in Lung Cancer Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-01, primaryCompletionDateStruct date: 2027-11, completionDateStruct date: 2028-11, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: West China Hospital, class: OTHER, descriptionModule briefSummary: 1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer.2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period.3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer., conditionsModule conditions: Sarcopenia, conditions: Lung Cancer, conditions: Ultrasound, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 1500, type: ESTIMATED, armsInterventionsModule interventions name: ultrasound scan, interventions name: CT/MRI scan, outcomesModule primaryOutcomes measure: Death, primaryOutcomes measure: Perioperative complications, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 100 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Xinyi Tang, status: RECRUITING, city: Chengdu, state: Sichuan, country: China, contacts name: Xinyi Tang, Dr., role: CONTACT, phone: +8615680819215, geoPoint lat: 30.66667, lon: 104.06667, hasResults: False
protocolSection identificationModule nctId: NCT06327568, orgStudyIdInfo id: IEO 1663, briefTitle: Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-06-17, primaryCompletionDateStruct date: 2026-06-17, completionDateStruct date: 2029-06-17, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-26, sponsorCollaboratorsModule leadSponsor name: European Institute of Oncology, class: OTHER, descriptionModule briefSummary: Human papillomavirus (HPV) infection has been implicated as a necessary cause for the development of the majority of anogenital neoplasms which represent approximately 95% of anal tumors. Persistent high risk HR-HPV infection promotes progression from intraepithelial lesions high-grade squamous anal tumors (AIN) (H-SIL) to invasive anal tumors.The diagnosis of AIN is made by cytology or biopsy during routine examinations. To date, no HPV test has been clinically validated for anal specimens and none are available in the molecular diagnostics market for this purpose.The performance analysis of an HPV Test with simultaneous genotyping on anal samples could implement anal cancer screening without an invasive procedure and with one simple approach., conditionsModule conditions: Anal Intraepithelial Neoplasia 2, conditions: Anal Intraepithelial Neoplasia 1, conditions: Anal Cancer, conditions: High-Risk Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: Sensitivity and specificity of BD Onclarity HPV assay for HPV detection and genotyping in case/control patients., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: European Institute of Oncology, status: RECRUITING, city: Milan, country: Italy, contacts name: Fabio Bottari, role: CONTACT, contacts name: Cristina Trovato, MD, role: SUB_INVESTIGATOR, contacts name: Anna Daniela Iacobone, MD, role: SUB_INVESTIGATOR, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False
protocolSection identificationModule nctId: NCT06327529, orgStudyIdInfo id: 2101814, briefTitle: Zinc and Iron Absorption From Common Beans in Young Adult Women, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-08-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-26, sponsorCollaboratorsModule leadSponsor name: University of California, Davis, class: OTHER, descriptionModule briefSummary: Fifteen female study participants will be enrolled in a randomized crossover study to measure fractional and total zinc and iron absorption from four common bean (Phaseolus vulgaris) varieties with varying phytate and polyphenolic contents. Phytate, the storage form of phosphorus in plants, and polyphenols, which contribute to the varied colors of common beans, are natural components of the beans and can reduce zinc and iron bioavailability from these foods., conditionsModule conditions: Zinc Absorption, conditions: Iron Absorption, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: A four arm multi-tracer non-randomized crossover design, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: SINGLE, maskingDescription: Study participants will be masked to the type of bean that they will be receiving., whoMasked: PARTICIPANT, enrollmentInfo count: 15, type: ESTIMATED, armsInterventionsModule interventions name: SER 118, interventions name: LMP 1001, interventions name: LPA 586, interventions name: KAT B1, outcomesModule primaryOutcomes measure: Fractional Zinc absorption, primaryOutcomes measure: Fractional Iron absorption, secondaryOutcomes measure: Total Zinc absorption, secondaryOutcomes measure: Total Iron absorption, eligibilityModule sex: FEMALE, minimumAge: 19 Years, maximumAge: 24 Years, stdAges: ADULT, contactsLocationsModule locations facility: Department of Nutrition, city: Davis, state: California, zip: 95616, country: United States, geoPoint lat: 38.54491, lon: -121.74052, hasResults: False
protocolSection identificationModule nctId: NCT06327516, orgStudyIdInfo id: M2020023, briefTitle: Lysophosphatidylglycerol in Asthma Pathogenesis, statusModule overallStatus: RECRUITING, startDateStruct date: 2015-01-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-26, sponsorCollaboratorsModule leadSponsor name: Peking University Third Hospital, class: OTHER, descriptionModule briefSummary: The study aims to investigate the relationship between the small molecule metabolite lysophosphatidylglycerol and asthma clinical features and explore its involvement in asthma pathogenesis., conditionsModule conditions: Asthma, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 250, type: ESTIMATED, outcomesModule primaryOutcomes measure: lipidomics, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Peking university third hospital, status: RECRUITING, city: Beijing, state: None Selected, zip: 100191, country: China, contacts name: Chun Chang, role: CONTACT, phone: 15810075362, email: doudou1977bysy@sina.com, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06327490, orgStudyIdInfo id: UF-BRE-012, briefTitle: A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06, primaryCompletionDateStruct date: 2028-06, completionDateStruct date: 2028-06, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-22, sponsorCollaboratorsModule leadSponsor name: University of Florida, class: OTHER, descriptionModule briefSummary: Breast cancer is estimated to affect approximately 300,000 women in the US in 2023. Studies demonstrate that 1 in 5 will develop breast cancer related lymphedema secondary to the treatments that they receive. BCRL at this time has no cure, however early detection can prevent the progression to late stage BCRL. At this time a technique of arm massage, manual lymphatic drainage (MLD), is used for treatment. This study investigates a new method of MLD, which is guided by the individual patients' lymphatic anatomy through use of ICG-lymphography., conditionsModule conditions: Breast Cancer, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: ICG-guided manual lymphatic drainage, interventions name: Traditional manual lymphatic drainage, outcomesModule primaryOutcomes measure: Subject compliance, secondaryOutcomes measure: Relative volume change, secondaryOutcomes measure: Bioimpedance, secondaryOutcomes measure: Breast cancer related lymphedema symptoms, secondaryOutcomes measure: Incidence of progression to late stage breast cancer related lymphedema, secondaryOutcomes measure: Health-related quality of life, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 99 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Florida, city: Gainesville, state: Florida, zip: 32610, country: United States, contacts name: Lisa Spiguel, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 29.65163, lon: -82.32483, hasResults: False
protocolSection identificationModule nctId: NCT06327438, orgStudyIdInfo id: REC/211/MTI.PT/2401041, briefTitle: Effect of Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema: A Randomized Control Trial, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-16, primaryCompletionDateStruct date: 2024-06-16, completionDateStruct date: 2024-07-16, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: South Valley University, class: OTHER, descriptionModule briefSummary: To examine the efficacy of complex decongestive therapy (CDT), cryotherapy and kinesio taping (KT) in patients with post-mastectomy lymphedema, conditionsModule conditions: Breast Neoplasms, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: randomized controlled study, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Complex decongestive therapy, interventions name: Cryotherapy, interventions name: Kinesio taping, outcomesModule primaryOutcomes measure: Arm girth measurement is measured by Circumferential measurements, primaryOutcomes measure: Pain severity is measured by VAS, secondaryOutcomes measure: The QOL is measured by SF-36, secondaryOutcomes measure: Range of motion (ROM) is measured by UG, eligibilityModule sex: ALL, minimumAge: 40 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Ragaee Saeed Mahmoud, status: RECRUITING, city: Giza, state: Faisal, country: Egypt, contacts name: Ragaee Mahmoud, role: CONTACT, phone: 00201223611112, email: ragaeesaeedpt10@gmail.com, contacts name: Reham Mahmoud, role: CONTACT, phone: 00201015447798, email: rsm_211pt@yahoo.com, geoPoint lat: 30.00808, lon: 31.21093, locations facility: Ragaee Saeed Mahmoud, status: RECRUITING, city: Faisal, state: Giza, zip: 002, country: Egypt, contacts name: Reham Saeed, Doctora, role: CONTACT, phone: 00201223611112, email: rsm_Pt211@yahoo.com, contacts name: Rabab Saeed, Doctora, role: CONTACT, phone: 00201017855222, email: rababSaeed10@yahoo.com, geoPoint lat: 30.01744, lon: 31.20376, hasResults: False
protocolSection identificationModule nctId: NCT06327425, orgStudyIdInfo id: MCG-Tachyarrhythmia, briefTitle: MCG for Localization of Tachyarrhythmia's Origin, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-14, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2025-02, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Qilu Hospital of Shandong University, class: OTHER, descriptionModule briefSummary: This is an exploratory research aiming to accurately identify the site of origin of tachyarrhythmia using Magnetocardiography (MCG), which will have guiding significance for early diagnosis, the formulation of treatment plans and preoperative positioning for radiofrequency ablation., conditionsModule conditions: Tachyarrhythmia, conditions: Atrial Flutter, conditions: Paroxysmal Supraventricular Tachycardia, conditions: Atrial Tachycardia, conditions: Atrial Fibrillation, conditions: Premature Ventricular Contraction, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: DIAGNOSTIC, maskingInfo masking: NONE, enrollmentInfo count: 1000, type: ESTIMATED, armsInterventionsModule interventions name: Magnetocardiography, outcomesModule primaryOutcomes measure: Efficacy of MCG to detect the site of origin of Tachyarrhythmia using cardiac electrophysiology as a reference standard., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 79 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06327412, orgStudyIdInfo id: KayseriCHLYMP01, briefTitle: The Effects of Aerobic Exercise in Patients With Primary Lower Extremity Lymphedema, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-10-01, completionDateStruct date: 2024-10-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-27, sponsorCollaboratorsModule leadSponsor name: Kayseri City Hospital, class: OTHER_GOV, descriptionModule briefSummary: Our aim in this study is to evaluate the effects of lymphedema on exercise capacity, body composition, functional level and quality of life in lymphedema patients with primary lower extremity involvement., conditionsModule conditions: Primary Lymphedema, conditions: Aerobic Exercise, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: A total of 35 patients with primary stage 2 and 3 lower extremity lymphedema, aged 18-65, who apply to the lymphedema outpatient clinic and meet the criteria of the International Society of Lymphology, will be included. Patients participating in the study will be randomized into 2 groups: aerobic exercise group (Group 1) and home exercise group (Group 2). According to randomization, 18 patients will be included in one group and 17 patients in the other.Cardiopulmonary exercise test (CPET), 30-second-stand-sit test (30s-CST), 6-minute walk test (6MWT), Lymphedema Circumference and Volume Measurement, Bioimpedance Measurement, Lower Extremity Functional Scale (LEFS), Lymphedema Life Impact Scale ( LLIC), Hospital Depression and Anxiety Scale (HADS), Numerical Rating Scale (NRS) forms will be filled in the cardiopulmonary rehabilitation unit of Kayseri City Hospital in the 0th, 4th and 16th weeks., primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 35, type: ESTIMATED, armsInterventionsModule interventions name: Aerobic exercise on the treadmill, interventions name: Walking between 12-13 RPE (The Borg Rating of Perceived Exertion) according to the Modified Borg Scale, outcomesModule primaryOutcomes measure: 30-second sit-stand test (30-s chair-stand test, 30s-CST), secondaryOutcomes measure: Cardiopulmonary exercise test (CPET), secondaryOutcomes measure: 6-minute walk test (6MWT), secondaryOutcomes measure: Circumference and volume measurement, secondaryOutcomes measure: Bioimpedance measurement, secondaryOutcomes measure: Lower Extremity Functional Scale (LEFS), secondaryOutcomes measure: Lymphedema Life Impact Scale (LLIC), secondaryOutcomes measure: Hospital Anxiety and Depression Scale (HADS), secondaryOutcomes measure: Numerical Rating Scale (NRS), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Health Sciences University, Kayseri Medicine Faculty, Kayseri City Hospital, city: Kayseri, zip: 38080, country: Turkey, geoPoint lat: 38.73222, lon: 35.48528, hasResults: False
protocolSection identificationModule nctId: NCT06327399, orgStudyIdInfo id: MS-373-2023, briefTitle: Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation., statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-21, primaryCompletionDateStruct date: 2024-04, completionDateStruct date: 2024-05, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-03-25, sponsorCollaboratorsModule leadSponsor name: Kasr El Aini Hospital, class: OTHER, descriptionModule briefSummary: Dexmedetomidine bolus dose may provide similar or less hemodynamic changes (less bradycardia and less hypertension) than infusion dose during induction of anaesthesia and tracheal intubation., conditionsModule conditions: Dexmedetomidine, conditions: Intubation Complication, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 70, type: ESTIMATED, armsInterventionsModule interventions name: Dexmedetomidine infusion, interventions name: Dexmedetomidine bolus, interventions name: Atropine Sulfate, interventions name: Ephedrine, interventions name: Propofol, outcomesModule primaryOutcomes measure: Mean blood pressure upon laryngoscopy, secondaryOutcomes measure: Blood pressure & Heart rate, secondaryOutcomes measure: Propfol, secondaryOutcomes measure: Bradycardia, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Cairo University Hospitals, status: RECRUITING, city: Giza, zip: 11562, country: Egypt, contacts name: Maher a Fawzy, MD, role: CONTACT, phone: 01201730249, email: kasralainirec@kasralainy.edu.eg, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06327360, orgStudyIdInfo id: FDG_ 88-16, briefTitle: Illness Expectations in Pulmonary Fibrosis, acronym: CAMFP, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2023-10-10, primaryCompletionDateStruct date: 2023-10-10, completionDateStruct date: 2025-10-01, studyFirstPostDateStruct date: 2024-03-25, lastUpdatePostDateStruct date: 2024-04-05, sponsorCollaboratorsModule leadSponsor name: Fondazione Don Carlo Gnocchi Onlus, class: OTHER, collaborators name: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, collaborators name: FIMARP ONLUS - FEDERAZIONE ITALIANA IPF E MALATTIE POLMONARI RARE, descriptionModule briefSummary: This study aims to delve into the constructs of illness beliefs and expectations among patients with Pulmonary Fibrosis, exploring how these beliefs and expectations may influence the treatment journey, including oxygen therapy, non-invasive ventilation therapy, and pharmacological treatments., conditionsModule conditions: Pulmonary Fibrosis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 130, type: ESTIMATED, armsInterventionsModule interventions name: Psychological questionnaires, outcomesModule primaryOutcomes measure: Adherence to Pharmacological Treatment, primaryOutcomes measure: Adherence to Oxygen Therapy, primaryOutcomes measure: Adherence to Non invasive ventilation, primaryOutcomes measure: Illness beliefs, primaryOutcomes measure: Pharmacological treatment Beliefs, primaryOutcomes measure: Illness Expectations, primaryOutcomes measure: Illness Cognitions, secondaryOutcomes measure: Socio-demographic variables, secondaryOutcomes measure: Clinical and medical data, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, city: Milano, zip: 20122, country: Italy, geoPoint lat: 45.46427, lon: 9.18951, locations facility: Don Gnocchi Foundation, city: Milano, zip: 20148, country: Italy, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False